Using gastric cancer and breast cancer models, propolis targeted the inflammatory cascade by downregulating Toll-like receptor 4 (TLR-4), glycogen synthase kinase 3 beta (GSK3 β), and NF-κB signaling pathways [144,157,162]. This evidence concerns the gene TLR4 and breast carcinoma.